Results 31 to 40 of about 59,989 (270)

Eosinophilic Esophagitis in the Middle East: Insight From a Comprehensive Systematic Review. [PDF]

JGH Open
ABSTRACT Background Eosinophilic esophagitis (EoE) is a chronic, immune‐mediated inflammatory disease of the esophagus, defined by esophageal dysfunction and dense eosinophilic infiltration (≥ 15 eosinophils per HPF) in biopsies, after exclusion of other causes.
Alwisi N, Moqeeth SA, Al-Mohannadi M.
europepmc   +2 more sources

The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trial

Journal of Research in Medical Sciences, 2021
Background: Gastroesophageal reflux disease (GERD) is a common upper gastrointestinal disorder with a negative impact on the quality of life. This study was aimed to assess the effect of adding duloxetine to lansoprazole on the symptom and quality of ...
Marjan Mokhtare, Arezoo Chaharmahali, Mansour Bahardoust, Atefeh Ghanbari, Arash Sarveazad, Roozbeh Naghshin, Farbod Abbaskhanidavanloo   +6 more
doaj   +1 more source

Iodine and pregnancy – a qualitative study focusing on dietary guidance and information [PDF]

, 2018
Iodine is essential for thyroid hormones synthesis and normal neurodevelopment; however, ~60% of pregnant women do not meet the WHO (World Health Organization) recommended intake.
Bouga, Maria, Combet, Emilie, Lean, Michael E.J.   +2 more
core   +2 more sources

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Current Therapeutic Research, 2016
Background: For many patients, current treatments do not adequately resolve heartburn in nonerosive reflux disease (NERD). Objective: To compare vonoprazan and placebo with respect to the frequency and severity of heartburn in patients with NERD. Methods:
Yoshikazu Kinoshita, MD, PhD, Yuuichi Sakurai, MPharm, Madoka Shiino, MPharm, Kentaro Kudou, MS, Akira Nishimura, BSc, MBA, Takuya Miyagi, MD, PhD, Katsuhiko Iwakiri, MD, PhD, Eiji Umegaki, MD, PhD, Kiyoshi Ashida, MD, PhD   +8 more
doaj   +1 more source

Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux. [PDF]

, 2017
PurposeAcid neutralization during chemical clearance is significantly prolonged in children with cystic fibrosis, compared to symptomatic children without cystic fibrosis.
Di Lorenzo, Carlo, Hayes, Don, Jadcherla, Sudarshan R, Kaul, Ajay, Kopp, Benjamin T, Machado, Rodrigo Strehl, Moore-Clingenpeel, Melissa, Mousa, Hayat, Nemastil, Christopher J, Woodley, Frederick W   +9 more
core   +3 more sources

Treatment of Gastrointestinal Disorders—Plants and Potential Mechanisms of Action of Their Constituents

Molecules, 2022
The worldwide prevalence of gastrointestinal diseases is about 40%, with standard pharmacotherapy being long-lasting and economically challenging. Of the dozens of diseases listed by the Rome IV Foundation criteria, for five of them (heartburn, dyspepsia,
Szilvia Czigle, Silvia Bittner Fialová, Jaroslav Tóth, Pavel Mučaji, Milan Nagy, on behalf of the OEMONOM   +5 more
doaj   +1 more source

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk, Brenner, Baruch, Galle, Peter R., Gockel, Ines, Klautke, Gunther, Lang, Hauke, Möhler, Markus, Roessler, Hans-Peter, Rödel, Claus, Schimanski, Carl Christoph, Schmidberger, Heinz, Thomaidis, Thomas, Trarbach, Tanja   +12 more
core   +1 more source

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials

BMC Gastroenterology, 2018
Background A two-week course of therapy with an over-the-counter proton-pump inhibitor (PPI) is recommended for frequent heartburn. Limited research has been conducted on the sustained efficacy of short-term PPI therapy after treatment cessation ...
David A. Peura, Anne Le Moigne, Heather Wassel, Charles Pollack   +3 more
doaj   +1 more source

Ocular Side Effects of Sildenafil That Persist Beyond 24 h—A Case Series

Frontiers in Neurology, 2020
Acute secondary effects of sildenafil, a first-line pharmacotherapy for erectile dysfunction (ED), include headache, heartburn, skin flush, and vision changes. Generally, these effects subside within 5 h.
Cüneyt Karaarslan
doaj   +1 more source

Gastroesophageal reflux disease: risk factors, current possibilities of diagnosis and treatment optimisation

Медицинский совет, 2022
Gastroesophageal reflux disease (GERD) is one of the most common causes of health care seeking at the primary care level in many countries. At an epidemiological level, GERD has been shown to be associated with a number of risk factors: obesity, tobacco ...
I. V. Maev, D. N. Andreev, M. A. Ovsepyan, E. V. Barkalova   +3 more
doaj   +1 more source